col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


9 Results       Page 1

 [1] 
Universitas Muhammadiyah Palangkaraya: Journal of Molecular Docking
  original article Date Title Authors   All Authors
1 [GO] 2023―Aug―25 Alantolactone: A Potential Multitarget Drug candidate for Prevention of SARS-CoV-2 Cell Entry Erum Zafar, Zainab Ahsan, Muhammad Faisal Maqbool, Aqsa Zaman, Sameena Gul, Amara Maryam, et al. (+3)
2 [GO] 2023―Aug―25 Docking and Dynamics Study of Phytochemicals as Potent Inhibitors against SARS-CoV-2 Main Protease Palla Ramprasad, Arunkumar Babu, Suveena Sukumaran
3 [GO] 2022―Dec―30 Comparative In-Silico Molecular Docking of Silymarin for SARS-CoV-2 Receptor Michael Antony Samy Amutha Gnana Arasi, Sapthasri Ravichandran, Irudayam Iayaraman
4 [GO] 2022―Feb―02 In Silico Anti-Inflammation Prediction of Glycyrrhiza Extracts Against Covid-19 Mansoureh Nazari
5 [GO] 2022―Feb―02 Corrigendum to "Development of SARS-CoV-2 Inhibitors Using Molecular Docking Study with Different Coronavirus Spike Protein and ACE2” [J Mol Docking. 2021;1(2):1-14] Israa Mohamed Shamkh, Dina Pratiwi, Hanaa S. Omar
6 [GO] 2022―Feb―02 In Silico Study for Similar FDA Approved Drugs as Inhibitors of SARS-CoV-2 Spike and the Host Receptor Proteins Israa Mohamed Shamkh, Dina Pratiwi, Hanaa S. Omar, Nour El-Houda A. Reyad
7 [GO] 2021―Jun―29 Development of SARS-CoV-2 Inhibitors Using Molecular Docking Study with Different Coronavirus Spike Protein and ACE2 Israa Mohamed Shamkh, Dina Pratiwi
8 [GO] 2021―Jun―29 Molecular Docking Studies of Phytoconstituents Identified in Traditional Siddha Polyherbal Formulations Against Possible Targets of SARS-CoV-2 Logesh Kumar Selvaraj, Geethanjali Thayumanavan, Srikanth Jeyabalan, Sugin Lal Jabaris
9 [GO] 2021―Jun―29 A Comparative Study of Approved Drugs for SARS-CoV-2 by Molecular Docking Achal Mishra, Radhika Waghela
 [1] 

9 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.016 sec